As of December 2023 Genmab has a market cap of $20.79 Billion. This makes Genmab the world's 848th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2023 | $20.79 B | -25.62% |
2022 | $27.95 B | 6.75% |
2021 | $26.18 B | -1.86% |
2020 | $26.68 B | 85.08% |
2019 | $14.41 B | 43.77% |
2018 | $10.02 B | -0.52% |
2017 | $10.08 B | 0.47% |
2016 | $10.03 B | 25.41% |
2015 | $8.00 B | 138.74% |
2014 | $3.35 B | 65.01% |
2013 | $2.03 B | 192.75% |
2012 | $0.69 B | 136.2% |
2011 | $0.29 B | -51.56% |
2010 | $0.60 B |
On Dec 10th, 2023 the market cap of Genmab was reported to be: